Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02384005 · ClinicalTrials.gov registry record · NA

The Feasibility of Self or Partner-assisted Digital Anal Exam Screening

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
201
Enrollment target

NCT02384005: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT02384005 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02384005, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target

Study Summary

There is no standard screening protocol for anal cancer even as disease incidence increases. This single-visit study will clarify if single persons can do a self-digital anal exam, or perhaps the exam requires a partner, or if, in fact, the exam requires a clinician for reasons of safety, accuracy, or acceptability. The investigators hypothesize that men having sex with men's digital anal exam (DAE) findings will have moderate or substantial agreement with a nurse practitioner DAE for detecting an anal abnormality (defined as condylomas, hemorrhoids, fissures, and malignant tumors). As a secondary hypothesis the investigator believe a partner-assisted DAE conducted within a couple will have better agreement with the nurse practitioner DAE than will a self-DAE conducted by a single person.

Interventions

  • OTHER Self-anal exam arm

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2015-02
Est. Completion 2016-04
Phase NA

What the finished NCT02384005 record still lists

NCT02384005 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Self-anal exam arm is the first listed.

NCT02384005 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02384005 about?

NCT02384005 is a clinical study titled "The Feasibility of Self or Partner-assisted Digital Anal Exam Screening". There is no standard screening protocol for anal cancer even as disease incidence increases. This single-visit study will clarify if single persons can do a self-digital anal exam, or perhaps the exam requires a partner, or if, in fact, the exam requires a clinician for reasons of safety, accuracy, ...

What is the current status of trial NCT02384005?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2015-02. Estimated completion is 2016-04.

What interventions are being tested in trial NCT02384005?

The interventions under investigation include: Self-anal exam arm (OTHER).

Who is sponsoring clinical trial NCT02384005?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02384005's enrollment target sits among peer trials

201 506th of 2000 higher than 1,495 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04422652 · 201 participants · Phase 2

    Combination of Novel Therapies for CKD Comorbid Depression

  • NCT05327114 · 201 participants · Phase 2

    Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • NCT06099769 · 201 participants · Phase 2

    A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  • NCT06274528 · 201 participants · Phase 2

    DORA and LP in Alzheimer's Disease Biomarkers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02384005, the US trial registry maintained by the National Library of Medicine. NCT02384005 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.